 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/11/2018 |
$19.52 |
$20.56 |
$19.51 |
$19.82 |
14.10K | | 12/12/2018 |
$20.00 |
$21.16 |
$19.25 |
$20.44 |
25.10K | | 12/13/2018 |
$20.30 |
$20.90 |
$18.50 |
$18.98 |
46.60K | | 12/14/2018 |
$19.11 |
$20.75 |
$17.04 |
$17.88 |
40.60K | | 12/17/2018 |
$17.36 |
$18.17 |
$16.02 |
$17.50 |
50.20K |
|
|
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need. Co.'s late-stage clinical pipeline includes two candidates for severe genetic disorders: EDSIVO™ (celiprolol), which is a selective adrenergic modulator and a new chemical entity for the treatment of vascular Ehlers-Danlos syndrome; and ACER-001, which is a taste-masked, immediate release formulation of sodium phenylbutyrate, designed to treat urea cycle disorders and Maple Syrup Urine Disease. | |
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on December 11, 2018, ACER opened at $19.52, traded as high as $20.56 and as low as $19.51, and closed at $19.82. Trading volume was a total of 14.10K shares. On December 12, 2018, ACER opened at $20.00, traded as high as $21.16 and as low as $19.25, and closed at $20.44. Trading volume was a total of 25.10K shares. On December 13, 2018, ACER opened at $20.30, traded as high as $20.90 and as low as $18.50, and closed at $18.98. Trading volume was a total of 46.60K shares. On December 14, 2018, ACER opened at $19.11, traded as high as $20.75 and as low as $17.04, and closed at $17.88. Trading volume was a total of 40.60K shares. On December 17, 2018, ACER opened at $17.36, traded as high as $18.17 and as low as $16.02, and closed at $17.50. Trading volume was a total of 50.20K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/18/2008 |
|
| End date: |
12/17/2018 |
|
| Start price/share: |
$1.67 |
|
| End price/share: |
$17.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
947.90% |
|
| Average Annual Total Return: |
26.47% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$104,750.14 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 12/11/2018 | $19.82 | | 12/12/2018 | $20.44 | | 12/13/2018 | $18.98 | | 12/14/2018 | $17.88 | | 12/17/2018 | $17.50 |
|
|
